Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2026 · third_quarter · Q3
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Source: Senate LDA
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
Dietary Supplement Innovation Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
Oral Health Products Inclusion Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Oral Health Products Inclusion Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Oral Health Products Inclusion Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Do or Dye Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Do or Dye Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
GRAS Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
GRAS Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
GRAS Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Ban Harmful Food Dyes Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Ban Harmful Food Dyes Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
ACCESS Through OTC Innovation Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
ACCESS Through OTC Innovation Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
ACCESS Through OTC Innovation Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
GRAS Oversight and Transparency Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
GRAS Oversight and Transparency Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Dietary Supplement Regulatory Uniformity Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Dietary Supplement Regulatory Uniformity Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
Dietary Supplement Regulatory Uniformity Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Dietary Supplement Listing Act of 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Dietary Supplement Listing Act of 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Food Labeling Modernization Act of 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Food Labeling Modernization Act of 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Dietary Supplements Access Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Dietary Supplements Access Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Better FDA Act of 2025
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Better FDA Act of 2025
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
Better FDA Act of 2025
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Better FDA Act of 2025
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Better FDA Act of 2025
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
CLEAR LABELS Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
CLEAR LABELS Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Dietary Supplements Access Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Dietary Supplements Access Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
Oral Health Products Inclusion Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Oral Health Products Inclusion Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Oral Health Products Inclusion Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Oral Health Products Inclusion Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
GRAS Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
GRAS Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
ACCESS Through OTC Innovation Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
Over-the-Counter Monograph Drug User Fee Amendments
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
SAFE Sunscreen Standards Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches.
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
Better FDA Act of 2025
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
FDA Modernization Act 3.0
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023 Office of the US Trade Representative 2024 Review of Notorious Markets for Counterfeiting and Piracy: Comment Request; Request for comments
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023 Office of the US Trade Representative 2024 Review of Notorious Markets for Counterfeiting and Piracy: Comment Request; Request for comments
Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023
WIPPES Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
WIPPES Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
WIPPES Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
WIPPES Act
Client: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION · Firm: CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
- Pharmaceutical Tariffs
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year. - Proposed legislation on illicit trade for consumer healthcare products
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2026 · second_quarter · Q2
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year. - Proposed legislation on illicit trade for consumer healthcare products
- Pharmaceutical Tariffs
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
- H.R. 1219, Oral Health Products Inclusion Act - S.4587, Dietary Supplements Access Act - H.R.8933, Dietary Supplements Access Act - Pharmaceutical Tariffs - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
H.R.4958 - GRAS Act S.3122 - Better FDA Act of 2025 H.R. 7291 - GRAS Oversight and Transparency Act H.R. 8385 - Food Labeling Modernization Act of 2026 H.R. 8370 - Dietary Supplement Listing Act of 2026 H.R. 5027 - Ban Harmful Food Dyes Act H.R. 3722 - Do or Dye Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2026 · first_quarter · Q1
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.
H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
- Pharmaceutical Tariffs
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2025 · fourth_quarter · Q4
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - The Dietary Supplement Regulatory Uniformity Act - legislation that would restore a national standard for dietary supplements. - Dietary Supplement Drug Preclusion - legislation intended to clarify ingredients that can be used in dietary supplements.
H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
- Pharmaceutical Tariffs
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2025 · third_quarter · Q3
S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
H.R.4958 - GRAS Act - The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
- Pharmaceutical Tariffs
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2025 · second_quarter · Q2
H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - Legislative language on General Recognition of Safety and Effectiveness
- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act - Fluoride and fluoridated water - Additive Ingredients in Drug Products - Over-the-Counter Tests - Pediatric Labeling
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2025 · first_quarter · Q1
- Reauthorization of the Over the Counter Monograph User Fee Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - FDA Modernization Act 3.0
- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act
- The SHOP SAFE Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2024 · fourth_quarter · Q4
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023 Office of the US Trade Representative 2024 Review of Notorious Markets for Counterfeiting and Piracy: Comment Request; Request for comments
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2024 · third_quarter · Q3
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2024 · second_quarter · Q2
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2024 · first_quarter · Q1
Addition of oral care products to HSA/FSA accounts - no legislation as of yet. H.R. 4794 - Dietary Supplement Access Act
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2023 · fourth_quarter · Q4
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
Addition of oral care products to HSA/FSA accounts - no legislation as of yet. H.R. 4794 - Dietary Supplement Access Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2023 · third_quarter · Q3
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023
Addition of oral care products to HSA/FSA accounts - no legislation as of yet. H.R. 4794 - Dietary Supplement Access Act
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2023 · second_quarter · Q2
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Anticounterfeiting, SHOP SAFE Act - no legislation as of yet. Dietary Supplement Reform issues
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2023 · first_quarter · 1A
Lobbying activities related to children's pain relieving medicines and supply chain. Drug Shortages Protection Act - pending legislation.
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act -- not yet introduced.
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. Anticounterfeiting, SHOP SAFE Act - no legislation as of yet. Dietary Supplement Reform issues
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2022 · second_quarter · 2A
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022
OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2022 · fourth_quarter · Q4
OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity -- (Included in H.R. 2617, Consolidated Appropriations Act of 2023) S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes H.R.2617 - Consolidated Appropriations Act, 2023 H.R.7776 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2022 · third_quarter · Q3
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2022 · second_quarter · Q2
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2022 · first_quarter · Q1
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Improvments to the Dietary Supplement regulatory structure, no bill number S.1698 - Hemp Access and Consumer Safety Act
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2021 · fourth_quarter · Q4
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2021 · third_quarter · Q3
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022
OTC switch process -- no bill number Cures 2.0 -- no bill number S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2021 · second_quarter · Q2
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Improvments to the Dietary Supplement regulatory structure, no bill number S.1698 - Hemp Access and Consumer Safety Act
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics.
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2021 · first_quarter · Q1
Cosmetics reform -- no bill number Proposals impacting the pharmaceutical supply chain -- no bill number
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Improvments to the Dietary Supplement regulatory structure, no bill number
OTC switch process -- no bill number
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2020 · fourth_quarter · Q4
Pseudoephedrine -- Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient and oppose PSE restrictions such as a prescription requirement (no bill number). Mandatory recall authority of the FDA Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R.3164 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 S.930 - Allowing Greater Access to Safe and Effective Contraception Act S.1847/H.R. 3296 - Affordability is Access Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.6058 - SHOP SAFE Act of 2020 S.3431 - INFORM Consumers Act Legislation to increase domestic production of pharmaceuticals and the domestic supply chain. H.R. 6395 - National Defense Authorization Act for Fiscal Year 2021 S.4049 - National Defense Authorization Act for Fiscal Year 2021 HR 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2020 · third_quarter · Q3
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes H.R.3443 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 S.1895 - Lower Health Care Costs Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.4296 - Safe Cosmetics and Personal Care Products Act of 2019 Udall/Lowenthal consumer products plastics outline, proposal to address consumer plastics issues. No bill number. H.R.2296/S.1391 - More Efficient Tools to Realize Information for Consumers Act S.2740 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5279 - Cosmetic Safety Enhancement Act of 2019 21st Century Cures Act 2.0 (No bill number) H.R.2064 - To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes. S.1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R.748 - CARES Act Critical infrastructure and supply chain HR 8837 -- Continuing Appropriations Act, 2021 and Other Extensions Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2020 · second_quarter · Q2
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes H.R.3443 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 S.1895 - Lower Health Care Costs Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.4296 - Safe Cosmetics and Personal Care Products Act of 2019 Udall/Lowenthal consumer products plastics outline, proposal to address consumer plastics issues. No bill number. H.R.2296/S.1391 - More Efficient Tools to Realize Information for Consumers Act S.2740 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5279 - Cosmetic Safety Enhancement Act of 2019 21st Century Cures Act 2.0 (No bill number) H.R.2064 - To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes. S.1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R.748 - CARES Act Critical infrastructure and supply chain
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2020 · first_quarter · Q1
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2019 · fourth_quarter · Q4
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes H.R.3443 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 S.1895 - Lower Health Care Costs Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.4296 - Safe Cosmetics and Personal Care Products Act of 2019 Udall/Lowenthal consumer products plastics outline, proposal to address consumer plastics issues. No bill number. H.R.2296/S.1391 - More Efficient Tools to Realize Information for Consumers Act S.2740 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5279 - Cosmetic Safety Enhancement Act of 2019 21st Century Cures Act 2.0 (No bill number) H.R.2064 - To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes. S.1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2019 · third_quarter · Q3
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes H.R.3443 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 S.1895 - Lower Health Care Costs Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.4296 - Safe Cosmetics and Personal Care Products Act of 2019 Udall/Lowenthal consumer products plastics outline, proposal to address consumer plastics issues. No bill number. H.R.2296 - More Efficient Tools to Realize Information for Consumers Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2019 · second_quarter · Q2
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes H.R.3443 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 S.1895 - Lower Health Care Costs Act
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2019 · first_quarter · Q1
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2018 · fourth_quarter · Q4
Dextromethorphan H.R. 1271, the "DXM Abuse Prevention Act" (DAP) - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. Tableting and Encapsulating Machine Regulation Act of 2018, no bill number. Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R. 5628/S. 2645 Access to Increased Drug Disposal Act of 2018. Establishes a demonstration program under which the Drug Enforcement Administration provides grants and technical assistance to certain States to enable those States to increase participation in drug take-back programs. H.R.6 - SUPPORT for Patients and Communities Act. This bill makes several changes to state Medicaid programs to address opioid and substance use disorders. The bill also alters Medicare requirements to address opioid use. Additionally, the bill temporarily eliminates the enhanced federal matching rate for Medicaid expenditures regarding specified medical services provided by certain managed care organizations.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2018 · third_quarter · Q3
Dextromethorphan H.R. 1271, the "DXM Abuse Prevention Act" (DAP) - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. Tableting and Encapsulating Machine Regulation Act of 2018, no bill number. Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R. 5628/S. 2645 Access to Increased Drug Disposal Act of 2018. Establishes a demonstration program under which the Drug Enforcement Administration provides grants and technical assistance to certain States to enable those States to increase participation in drug take-back programs. H.R.6 - SUPPORT for Patients and Communities Act. This bill makes several changes to state Medicaid programs to address opioid and substance use disorders. The bill also alters Medicare requirements to address opioid use. Additionally, the bill temporarily eliminates the enhanced federal matching rate for Medicaid expenditures regarding specified medical services provided by certain managed care organizations.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2018 · second_quarter · Q2
OTC Drug Review Monograph H.R 5333/S.2315 - Over-the-Counter Drug Safety, Innovation, and Reform Act. Legislation to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.
Dextromethorphan H.R. 1271, the "DXM Abuse Prevention Act" (DAP) - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. Tableting and Encapsulating Machine Regulation Act of 2018, no bill number. Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R. 5628/S. 2645 Access to Increased Drug Disposal Act of 2018. Establishes a demonstration program under which the Drug Enforcement Administration provides grants and technical assistance to certain States to enable those States to increase participation in drug take-back programs.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2018 · first_quarter · Q1
OTC Drug Review Monograph H.R 5333/S.2315 - Over-the-Counter Drug Safety, Innovation, and Reform Act. Legislation to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.
Dextromethorphan H.R. 1271, the "DXM Abuse Prevention Act" (DAP) - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. Tableting and Encapsulating Machine Regulation Act of 2018, no bill number. Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. Access to Increased Drug Disposal Act of 2018, no bill number. Establishes a demonstration program under which the Drug Enforcement Administration provides grants and technical assistance to certain States to enable those States to increase participation in drug take-back programs.
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2017 · fourth_quarter · Q4
OTC Drug Review Monograph Legislation (no bill number) to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2017 · third_quarter · Q3
OTC Drug Review Monograph Legislation (no bill number) to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
2017 · second_quarter · Q2
OTC Drug Review Monograph Legislation (no bill number) to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1999 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION via CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
1999 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
- The SHOP SAFE Act - Advocacy to protect funding for the Office of the Intellectual Property Enforcement Coordinator (IPEC) and to advocate for an IPEC appointment before the end of the year.
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
- Pharmaceutical Tariffs
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
- Pharmaceutical Tariffs
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA) Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act S.5243 - Cannabinoid Safety and Regulation Act
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023 Issues related to pharmaceutical tariffs
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023 Office of the US Trade Representative 2024 Review of Notorious Markets for Counterfeiting and Piracy: Comment Request; Request for comments
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA) Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act S.5243 - Cannabinoid Safety and Regulation Act
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA) Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA)
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Addition of oral care products to HSA/FSA accounts - no legislation as of yet. Addition of dietary supplements to HSA/FSA accounts - no legislation as of yet.
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act -- not yet introduced. FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Addition of oral care products to HSA/FSA accounts - no legislation as of yet. Addition of dietary supplements to HSA/FSA accounts - no legislation as of yet.
S.150 - Affordable Prescriptions for Patients Act of 2023
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity S. 4535 - Food and Drug Administration Simple Reauthorization Act of 2022 or the "FDASRA Act of 2022" H.R.6833 - Making continuing appropriations for fiscal year 2023, and for other purposes
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 S.1698 - Hemp Access and Consumer Safety Act S. 4090 - Dietary Supplement Listing Act of 2022
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
OTC switch process -- no bill number H.R. 6000 - 21st Century Cures 2.0 S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 H.R. 7667 - Food and Drug Amendments of 2022 Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022 or the FDASLA Act of 2022 Genus vs. FDA Circuit Court Lobby Activity
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes H.R.3617 - MORE Act of 2021 H.R.2591/S.957 - DUMP Opioids Act S.2628 - Better ODDS To Reduce Diversion Act of 2021 H.R.5086 - Safe Disposal of Opioids Act of 2021 H.R.5382/S.2853 - POWER Act H.R.4350 - National Defense Authorization Act for Fiscal Year 2022
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics. H.R.5376 - Build Back Better Act H.R.3684 - Infrastructure Investment and Jobs Act
OTC switch process -- no bill number Cures 2.0 -- no bill number S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021 Prescription Drug User Fee Act (PDUFA) -- no bill number Dietary Supplement Reform -- no bill number Cosmetics Reform -- no bill number
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Improvments to the Dietary Supplement regulatory structure, no bill number S.1698 - Hemp Access and Consumer Safety Act
OTC switch process -- no bill number Cures 2.0 -- no bill number S.1435/HR 2873 - Affordable Prescriptions for Patients Act of 2021 H.R.4405 - Small Business FDA User Fee Adjustment Act of 2021
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
H.R.841 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2021 Improvments to the Dietary Supplement regulatory structure, no bill number S.1698 - Hemp Access and Consumer Safety Act
Proposals impacting the pharmaceutical supply chain -- no bill number S.2100 - A bill to amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. H.R.3990/S. 2047 - To ban the use of intentionally added perfluoroalkyl or polyfluoroalkyl substances in cosmetics.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
OTC switch process -- no bill number Cures 2.0 -- no bill number
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
H.R.2051 - To designate methamphetamine as an emerging threat, and for other purposes S.854 - A bill to designate methamphetamine as an emerging threat, and for other purposes
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes H.R.3443 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 S.1895 - Lower Health Care Costs Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.4296 - Safe Cosmetics and Personal Care Products Act of 2019 Udall/Lowenthal consumer products plastics outline, proposal to address consumer plastics issues. No bill number. H.R.2296/S.1391 - More Efficient Tools to Realize Information for Consumers Act S.2740 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5279 - Cosmetic Safety Enhancement Act of 2019 21st Century Cures Act 2.0 (No bill number) H.R.2064 - To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes. S.1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R.748 - CARES Act Critical infrastructure and supply chain HR 8837 -- Continuing Appropriations Act, 2021 and Other Extensions Act H.R.133 - Consolidated Appropriations Act, 2021
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. H.R.2020/S.989 - STEER Act -- Tableting and Encapsulating Machine Regulation Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 H.R.3171 - Safe Disposal of Opioids Act of 2019 S.2584 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 S.2102 - Turn the Tide Act H.R.4510 - Criminalizing Abused Substance Templates Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 S.4612 - Methamphetamine Response Act of 2020 H.R.8210 - Methamphetamine Response Act of 2020
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. H.R.2020/S.989 - STEER Act -- Tableting and Encapsulating Machine Regulation Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 H.R.3171 - Safe Disposal of Opioids Act of 2019 S.2584 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 S.2102 - Turn the Tide Act H.R.4510 - Criminalizing Abused Substance Templates Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020
Pseudoephedrine -- Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient and oppose PSE restrictions such as a prescription requirement (no bill number). Mandatory recall authority of the FDA Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. H.R.3164 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 S.930 - Allowing Greater Access to Safe and Effective Contraception Act S.1847/H.R. 3296 - Affordability is Access Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.6058 - SHOP SAFE Act of 2020 S.3431 - INFORM Consumers Act Legislation to increase domestic production of pharmaceuticals and the domestic supply chain. H.R. 6395 - National Defense Authorization Act for Fiscal Year 2021 S.4049 - National Defense Authorization Act for Fiscal Year 2021 HR 8179 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
Food and Drug Administration (FDA) draft "Guidance for Industry: New Dietary Ingredient Notifications and Related Issues." Supports efforts to encourage FDA to develop a legal path for CBD as a new dietary ingredient. (no bill number) H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 S.1215 - National Defense Authorization Act for Fiscal Year 2020 S.2032 - A bill to expand research on the cannabidiol and marihuana. S.1717/H.R. 3142 - SNAP Vitamin and Mineral Improvement Act of 2019 H.R.1887 - National Institute of Nutrition Act H.R.1595 - Secure And Fair Enforcement Banking Act of 2019 S.2895 - SARMs Control Act of 2019 S.1790 - National Defense Authorization Act for Fiscal Year 2020 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5587 - To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. H.R.2020/S.989 - STEER Act -- Tableting and Encapsulating Machine Regulation Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 H.R.3171 - Safe Disposal of Opioids Act of 2019 S.2584 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 S.2102 - Turn the Tide Act H.R.4510 - Criminalizing Abused Substance Templates Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of, Vice President of the U.S.
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. H.R.2020/S.989 - STEER Act -- Tableting and Encapsulating Machine Regulation Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 H.R.3171 - Safe Disposal of Opioids Act of 2019 S.2584 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 S.2102 - Turn the Tide Act H.R.4510 - Criminalizing Abused Substance Templates Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020
H.R.269 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 -- To reauthorize certain programs under the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act with respect to public health security and all-hazards preparedness and response, to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes. H.R.648 - Consolidated Appropriations Act, 2019 -- Making appropriations for the fiscal year ending September 30, 2019, and for other purposes. Includes language authorizing the collection of Monograph Reform user fees. H.J.Res.28 - Further Additional Continuing Appropriations Act, 2019 - This joint resolution provides continuing FY2019 appropriations to several federal agencies through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. H.J.Res.31 - Consolidated Appropriations Act, 2019 -- This joint resolution provides continuing FY2019 appropriations for the Department of Homeland Security (DHS) through the earlier of February 15, 2019, or the enactment of the applicable appropriations legislation. It is known as a continuing resolution (CR) and ends the partial DHS shutdown that began on December 22, 2018, because the existing CR expired and the FY2019 DHS appropriations bill has not been enacted. H.R.268 - Supplemental Appropriations Act, 2019 -- This bill provides $12.1 billion in FY2019 supplemental appropriations to several federal departments and agencies for expenses related to the consequences of recent wildfires, hurricanes, volcanos, earthquakes, typhoons, and other natural disasters. S.726 - Personal Care Products Safety Act -- To amend the Federal Food, Drug, and Cosmetic Act to ensure the safety of cosmetics. Cosmetic Safety Enhancement Act of 2019 (Pallone/Shimkus discussion draft) -- To amend the Federal Food, Drug, and Cosmetic Act to improve cosmetic safety, and for other purposes H.R.3443 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 S.1895 - Lower Health Care Costs Act S.2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020 H.R.4296 - Safe Cosmetics and Personal Care Products Act of 2019 Udall/Lowenthal consumer products plastics outline, proposal to address consumer plastics issues. No bill number. H.R.2296/S.1391 - More Efficient Tools to Realize Information for Consumers Act S.2740 - Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020 H.R.5279 - Cosmetic Safety Enhancement Act of 2019 21st Century Cures Act 2.0 (No bill number) H.R.2064 - To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes. S.1391 - Fair Accountability and Innovative Research Drug Pricing Act of 2019 H.R.748 - CARES Act Critical infrastructure and supply chain
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, Treasury, Dept of
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. H.R.2020/S.989 - STEER Act -- Tableting and Encapsulating Machine Regulation Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 H.R.3171 - Safe Disposal of Opioids Act of 2019 S.2584 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 S.2102 - Turn the Tide Act H.R.4510 - Criminalizing Abused Substance Templates Act of 2019 H.R.1865 - Further Consolidated Appropriations Act, 2020
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. H.R.2020/S.989 - STEER Act -- Tableting and Encapsulating Machine Regulation Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 H.R.3171 - Safe Disposal of Opioids Act of 2019 S.2584 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2020 S.2102 - Turn the Tide Act H.R.4510 - Criminalizing Abused Substance Templates Act of 2019
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. Tableting and Encapsulating Machine Regulation Act, no bill number. Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs. H.R.3055 - Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020 H.R.3171 - Safe Disposal of Opioids Act of 2019
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
H.R.863 - DXM Abuse Prevention Act of 2019 - legislation that would ban the sale of over-the-counter cough and cold medications containing the active ingredient dextromethorphan (DXM) to minors under the age of 18. Additionally, would ban the sale of bulk, unfinished DXM to entities not registered with the U.S. Food and Drug Administration; all sections. Tableting and Encapsulating Machine Regulation Act, no bill number. Gives the Drug Enforcement Agency additional authority to regulate tableting and encapsulating manufacturing machines. FDA Packaging and Disposal, no bill number. Directs FDA to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II drugs, with an emphasis on opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to immediately inactivate/render unattractive unused drugs.
Filing targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
OTC Drug Review Monograph H.R. 5333/S.2315 - Over-the-Counter Drug Safety, Innovation, and Reform Act. Legislation to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs. H.R. 7328 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 H.R.6903 - Safe Cosmetics and Personal Care Products Act of 2018
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
OTC Drug Review Monograph H.R 5333/S.2315 - Over-the-Counter Drug Safety, Innovation, and Reform Act. Legislation to update and modernize the Over-the-Counter Drug Review Monograph system, which regulates the manufacture, labeling, and marketing of specific over-the-counter (OTC) drugs.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of